Teva Reaches Tentative $4.25 Billion Deal to Resolve Opioid Lawsuits
- July 29, 2022
Teva Pharmaceuticals Industries Ltd. would pay $4.25 billion over 13 years under a tentative nationwide settlement announced July 26 to resolve thousands of claims against the company for its alleged role in fueling the opioid epidemic.
ARTICLE TAGS
You must be logged in to access this content.